ISRCTN14654848
Completed
Not Applicable
Evaluating the safety and tolerability of intravenous administration of an RNA-lipoplex cancer vaccine targeting three tumor-associated antigens in patients with prostate cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male patients with prostate cancer
- •2\. Age 50\-90 years old
Exclusion Criteria
- •Unconfirmed cases of prostate cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81IRCT20140818018842N40Tehran University of Medical Sciences60
Completed
Not Applicable
Assessment on safety of intravenously administered trastuzumab with 100 ml saline solution in HER2 positive breast cancerBreast cancerJPRN-UMIN000006710Shiga University of Medical Science30
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10
Not yet recruiting
Phase 4
Efficacy and Saftey of Intravenous Versus Oral Iron Therapy in Postpartum Anemia - A Randomised Controlled TrialCTRI/2020/02/023125Department of Obstetrics And Gynecology
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80